Encapsulated cell therapy (Bavarian Nordic)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEncapsulated cell therapy (Bavarian Nordic)
Drug Alias NameCapCell
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCytochrome P450 gene transference
TargetsCytochrome P450
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBavarian Nordic A/S
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A